FibroBiologics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -140 | -137 | -130 | |
EBITDA | -352 | 1,043 | -8,319 | -9,586 |
EBIT | -495 | 903 | -8,456 | -9,716 |
Net Income | -500 | 898 | -8,460 | -9,717 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,617 | -2,013 | -4,283 | -1,603 |
Cash | 7,827 | 5,973 | 8,157 | 9,163 |
Basic Shares | 33,516 | 32,719 | 32,719 | 28,230 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -437 | -94 | |
EBITDA | -15,901 | -4,373 | -1,578 |
EBIT | -16,338 | -4,467 | |
Net Income | -16,485 | -5,121 | -1,582 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -6,896 | -4,066 | -1,410 |
Cash | 9,163 | 2,266 | 407 |
Basic Shares | 28,230 | 32,492 | 32,492 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.01 |
2024-06-30 | -$0.02 |
2024-03-31 | -$0.25 |
